Lars Valke

Dr. Lars Valke


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
JKJosephine Kranendonk
Josephine Kranendonk
SHSuzanne Holewijn
Suzanne Holewijn
LVLars Valke
Lars Valke
CKCornelis Kramers
Cornelis Kramers
MWMichiel Warlé
Michiel Warlé
HMHoushang Monajemi
Houshang Monajemi
Background/objective: To investigate the association between lipoprotein(a) (Lp(a)) concentrations, peripheral arterial disease (PAD), and the occurrence of major adverse cardiovascular events (MACE), or major adverse limb events (MALE). Methods: This prospective single center cohort study included 475 patients referred to a vascular center with suspected PAD de novo between January 13th 2017 and December 27th 2019. Serum Lp(a) concentrations were measured at baseline, and electronic patients’ records were reviewed for diagnosis of PAD at baseline, and the occurrence of MACE or MALE during follow-up. MACE was defined as a composite of myocardial infarction, unplanned percutaneous coronary intervention, ischemic cerebrovascular accident, transient ischemic attack, and cardiovascular death. MALE was defined as any endovascular or open revascularization or limbrelated vascular intervention performed due to PAD. Results: Of the 475 patients, 332 patients (69.9%) were diagnosed with PAD. Patients with PAD had significantly higher median LP(a) concentrations compared to those in whom PAD was ruled out (30 [11-77] mg/dL versus 19 [9-64] mg/dL, p=0.033), without differences in other lipid parameters. During a median follow-up of 6 years, 81 patients with PAD (24.4%) experienced MACE, and 141 patients (42.5%) experienced MALE. Univariate cox regression analysis showed that serum Lp(a) concentration was not significantly associated with MACE (HR 0.909, p=0.206), nor MALE (HR 1.000, p=0.995) in patients with PAD. Multivariate cox regression showed similar results. Conclusion: Patients who were diagnosed with PAD de novo had significantly higher Lp(a) concentrations, but Lp(a) was not significantly associated with occurrence of MACE or MALE.